MAVERICK CAPITAL LTD 13D and 13G filings for Atara Biotherapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-14 5:03 pm Sale |
2023-12-31 | 13G | Atara Biotherapeutics, Inc. ATRA |
MAVERICK CAPITAL LTD | 0 0.000% |
-251,641 (Position Closed) |
Filing |
| 2023-02-14 07:31 am Sale |
2022-12-31 | 13G | Atara Biotherapeutics, Inc. ATRA |
MAVERICK CAPITAL LTD | 251,641 6.600% |
-62,592 (-19.92%) |
Filing |
| 2022-03-11 5:05 pm Purchase |
2021-12-31 | 13G | Atara Biotherapeutics, Inc. ATRA |
MAVERICK CAPITAL LTD | 314,233 8.400% |
21,251 (+7.25%) |
Filing |
| 2021-02-16 1:41 pm Purchase |
2020-12-31 | 13G | Atara Biotherapeutics, Inc. ATRA |
MAVERICK CAPITAL LTD | 292,982 8.900% |
94,644 (+47.72%) |
Filing |